ImmunityBio Inc. (NASDAQ: IBRX) Could Soon Experience A Sharp Increase In Its Share Price. – Marketing Sentinel
Home  »  Technologies   »  ImmunityBio Inc. (NASDAQ: IBRX) Could Soon Experie...

ImmunityBio Inc. (NASDAQ: IBRX) Could Soon Experience A Sharp Increase In Its Share Price.

In the last trading session, 1.07 million shares of the ImmunityBio Inc. (NASDAQ:IBRX) were traded, and its beta was 2.03. Most recently the company’s share price was $8.81, and it changed around -$0.89 or -9.18% from the last close, which brings the market valuation of the company to $3.79B. IBRX currently trades at a discount to its 52-week high of $45.42, offering almost -415.55% off that amount. The share price’s 52-week low was $6.80, which indicates that the current value has risen by an impressive 22.81% since then. We note from ImmunityBio Inc.’s average daily trading volume that its 10-day average is 1.01 million shares, with the 3-month average coming to 844.59K.

ImmunityBio Inc. stock received a consensus recommendation rating of a Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended IBRX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. ImmunityBio Inc. is expected to report earnings per share of $0 for the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

ImmunityBio Inc. (NASDAQ:IBRX) trade information

Instantly IBRX has showed a red trend with a performance of -9.18% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 10.37 on Friday, 10/08/21 increased the stock’s daily price by 15.04%. The company’s shares are currently down -33.91% year-to-date, but still down -11.99% over the last five days. On the other hand, ImmunityBio Inc. (NASDAQ:IBRX) is -11.46% down in the 30-day period. We can see from the shorts that 9.51 million shares have been sold at a short interest cover period of 11.96 day(s).

The consensus price target as assigned by Wall Street analysts is $25.00, which translates to bulls needing to increase their stock price by 64.76% from its current value. Analyst projections state that IBRX is forecast to be at a low of $25.00 and a high of $25.00. In order for the stock price to hit the forecast high, the stock would need to plunge -183.77% from its current level, while the stock would need to crash -183.77% from its current level to reach the projected low.

ImmunityBio Inc. (IBRX) estimates and forecasts

The year-over-year growth rate is expected to be -9.90%, down from the previous year.

Consensus estimates provided by 1 financial analysts predict the company will bring in an average of $20k in revenue for the current quarter. 1 analysts expect ImmunityBio Inc. to make $20k in revenue for the quarter ending Dec 2021. Forecasts for the next quarter put sales growth at -4.80%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 23.10%. ImmunityBio Inc. earnings are expected to increase by -27.80% in 2021, but the outlook is negative -1.70% per year for the next five years.

IBRX Dividends

ImmunityBio Inc.’s next quarterly earnings report is expected to be released in November.

ImmunityBio Inc. (NASDAQ:IBRX)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 80.98% of ImmunityBio Inc. shares, and 7.31% of them are in the hands of institutional investors. The stock currently has a share float of 38.42%. ImmunityBio Inc. stock is held by 190 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Jun 29, 2021, it held 1.42% of the shares, which is about 5.56 million shares worth $79.4 million.

Blackrock Inc., with 1.35% or 5.27 million shares worth $75.3 million as of Jun 29, 2021, holds the second largest percentage of outstanding shares.

>> 7 Top Picks for the Post-Pandemic Economy <<

SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and iShares Russell 2000 ETF were the top two Mutual Funds as of Jun 29, 2021. The former held 2.98 million shares worth $42.58 million, making up 0.76% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 1.52 million shares worth around $21.73 million, which represents about 0.39% of the total shares outstanding.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam